查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594390

NGS 樣品製備市場：按產品、工作流程、技術、應用和最終用戶 - 2025-2030 年全球預測

NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年NGS樣本製備市場價值為24億美元，預計2024年將達27.8億美元，複合年成長率為16.01%，到2030年將達68億美元。

下一代定序 (NGS) 樣品製備包括製備用於定序的核酸所需的所有步驟，包括萃取、精製、片段化和文庫建構。這部分對於整個 NGS 流程至關重要，因為它可確保下游結果的樣本品質和準確性，促進基因組研究、醫學診斷和個人化醫療中的應用。由於臨床診斷、感染疾病監測和癌症基因組分析的需求不斷增加，NGS 市場正在經歷顯著成長。主要成長動力包括可實現更高通量和準確性的技術進步、基因組研究的擴散以及定序成本的下降。此外，人工智慧和自動化在樣品製備過程中的整合為市場參與者提供了提高效率和減少錯誤的有利可圖的機會。然而，市場成長面臨初始設置成本高、監管複雜性以及需要熟練人員運作先進 NGS 平台等挑戰。對於中小型企業來說，這些障礙可能尤其繁重。儘管面臨這些挑戰，創新仍然強勁，有前景的研究領域包括開發標準化、易於使用的套件和耗材，可以更有效地處理不同的樣品。鼓勵公司專注於夥伴關係和協作研究，以擴大其技術能力並整合創新方法，例如用於微流體樣品製備的實驗室晶片系統。對競爭格局的回顧表明，市場競爭激烈且發展迅速。保持技術前沿並提供可客製化且經濟高效的解決方案對於業務成長至關重要。 NGS 樣品製備市場的本質是動態的，並受到不斷的技術突破和應用擴展的推動。

主要市場統計
基準年[2023] 24億美元
預測年份 [2024] 27.8億美元
預測年份 [2030] 68億美元
複合年成長率（%） 16.01%

市場動態：揭示快速發展的 NGS 樣品製備市場的關鍵市場洞察

NGS 樣品製備市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 感染疾病的流行和早期診斷的需求日益成長
    • 新治療方法研發的 NGS 投資情況良好
    • 擴大NGS測序技術在農業領域的應用以實現永續生產力
  • 市場限制因素
    • NGS樣品製備平台高成本以及NGS樣品製備過程中的污染問題
  • 市場機會
    • NGS 樣品製備平台的技術進步
    • 加強私營和政府組織之間的協作和夥伴關係，以開發 NGS 樣品製備平台
  • 市場挑戰
    • 中小型實驗室缺乏熟練的專業人員

波特五力：駕馭 NGS 樣品製備市場的策略工具

波特五力框架是了解 NGS 樣品製備市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 NGS 樣品製備市場的外部影響

外部宏觀環境因素在塑造 NGS 樣品製備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 NGS 樣品製備市場的競爭格局

NGS 樣品製備市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 NGS 樣品製備市場供應商的績效評估

FPNV定位矩陣是評估NGS樣本製備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 NGS 樣品製備市場的成功之路

NGS 樣品製備市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病傳播日益蔓延，需要早期診斷
      • NGS 研究和開發新治療方法的有利投資環境
      • NGS定序技術在農業中的新用途，以實現永續生產力
    • 抑制因素
      • NGS樣品製備平台高成本以及NGS樣品製備過程中的污染問題
    • 機會
      • NGS 樣品製備平台的技術進步
      • 加強私營和政府組織之間的合作和夥伴關係，開發 NGS 樣品製備平台
    • 任務
      • 中小型實驗室缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 NGS 樣品製備市場：依產品

  • 試劑/耗材
  • 工作站

第7章 NGS 樣品製備市場：依工作流程

  • DNA
    • 人類全基因組序列分析（WGS）
    • 標靶定序
    • 全EXOME定序 (WES)
  • 準備圖書館
  • 品管
  • RNA
    • 基因表現分析
    • 全轉錄組序列分析
  • 靶向序列捕獲
    • 目標序列
    • 韋斯
    • 全EXOME定序 (WES)

第8章 NGS 樣品製備市場：依技術分類

  • 離子半導體定序
  • 奈米孔定序
  • 邊定序邊定序 (SBS)
  • 單分子即時 (SMRT)定序

第9章 NGS 樣品製備市場：依應用分類

  • 農業和動物研究
  • 疾病診斷
    • 癌症診斷
    • 感染疾病診斷
    • 生殖健康檢查
  • 藥物發現

第 10 章 NGS 樣品製備市場：依最終用戶分類

  • 學術機構與研究中心
  • 醫院/診所
  • 製藥和生物技術公司

第11章 美洲NGS樣品製備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區NGS樣本製備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲NGS樣品製備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 安捷倫改善了 NGS 樣品製備工作流程的使用者體驗
    • INTEGRA Biosciences 收購 Miroculus
    • Ultima Genomics 與 New England Biolabs 合作擴大 Ultima 定序儀的研究應用
    • QIAGEN 完成對 Verogen 的收購，利用 NGS 技術加強人類 ID/法醫學領先地位
    • 安捷倫宣布收​​購用於癌症研究的高性能 NGS靶向序列捕獲工作流程開發商 Avida Biomed
    • 整合式 DNA Technologies 推出完整的猴痘 NGS 文庫製備解決方案
    • 推出 NGS KAPA靶向序列捕獲產品
    • PerkinElmer 推出 BioQule NGS 系統來自動化文庫製備
    • 隆重介紹 Tecan 的 MagicPrep NGS - 滿足您的 NGS 文庫製備需求的即用型解決方案
    • Beckman Coulter Life Sciences 與 Illumina 簽署 Biomek NGeniuS 系統應用開發協議
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Applied Biological Materials Inc.
  • Aurora Biomed Inc.
  • Beckman Coulter by Danaher Corporation
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDynami
  • Eppendorf SE
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd.
  • FORMULATRIX, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Macrogen Inc.
  • Magen Biotechnology Co., Ltd.
  • MCLAB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer Inc.
  • Promega Corporation
  • Psomagen, Inc.
  • Qiagen NV
  • SPT Labtech Ltd
  • Standard BioTools Inc.
  • Sysmex Corporation
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation
Product Code: MRR-9F52358C4167

The NGS Sample Preparation Market was valued at USD 2.40 billion in 2023, expected to reach USD 2.78 billion in 2024, and is projected to grow at a CAGR of 16.01%, to USD 6.80 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation encompasses all necessary steps to prepare nucleic acids for sequencing, including extraction, purification, fragmentation, and library construction. This segment is indispensable to the overall NGS process, as it ensures sample quality and the accuracy of downstream results, facilitating applications in genomic research, medical diagnostics, and personalized medicine. With a rising demand in clinical diagnostics, infectious disease research, and cancer genomics, the NGS sample preparation market is witnessing significant growth. Key growth drivers include technological advancements delivering higher throughput and accuracy, a surge in genomic research, and the decreasing cost of sequencing. Additionally, the integration of artificial intelligence and automation in sample preparation processes presents lucrative opportunities for market players to enhance efficiency and reduce errors. However, market growth faces challenges such as the high initial setup cost, regulatory complexities, and the need for highly skilled personnel to run sophisticated NGS platforms. Small and medium-sized enterprises may find these barriers particularly prohibitive. Despite these challenges, innovation remains robust, with potential research areas including the development of standardized, user-friendly kits and consumables capable of handling diverse samples with greater efficiency. Companies are encouraged to focus on partnerships and collaborations to expand technological capabilities and integrate innovative approaches such as lab-on-a-chip systems for microfluidic sample preparation. Insight into the market reveals a competitive yet rapidly evolving landscape where staying at the forefront of technology and offering customizable and cost-effective solutions are vital for business growth. The nature of the NGS sample preparation market is dynamic, driven by continuous technological breakthroughs and an expanding array of applications, suggesting a promising future with opportunities for stakeholders willing to adapt and innovate accordingly.

KEY MARKET STATISTICS
Base Year [2023] USD 2.40 billion
Estimated Year [2024] USD 2.78 billion
Forecast Year [2030] USD 6.80 billion
CAGR (%) 16.01%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS Sample Preparation Market

The NGS Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases and rising need for early disease diagnosis
    • Favorable investment landscape in NGS for the research and development of new treatments
    • Emerging use of NGS sequencing technology in agriculture for sustainable productivity
  • Market Restraints
    • High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
  • Market Opportunities
    • Technological advancement in NGS sample preparation platforms
    • Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
  • Market Challenges
    • Limited availability of skilled professionals in medium and small size laboratories

Porter's Five Forces: A Strategic Tool for Navigating the NGS Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS Sample Preparation Market

A detailed market share analysis in the NGS Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS Sample Preparation Market

A strategic analysis of the NGS Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., Aurora Biomed Inc., Beckman Coulter by Danaher Corporation, BGI Group, Bio-Rad Laboratories, Inc., BioDynami, Eppendorf SE, Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd., FORMULATRIX, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen Inc., Magen Biotechnology Co., Ltd., MCLAB, Merck KGaA, New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, Psomagen, Inc., Qiagen N.V., SPT Labtech Ltd, Standard BioTools Inc., Sysmex Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the NGS Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Reagents & Consumables and Workstations.
  • Based on Workflow, market is studied across DNA, Library Preparation, Quality Control, RNA, and Target Enrichment. The DNA is further studied across Human Whole Genome Sequencing (WGS), Targeted Sequencing, and Whole Exome Sequencing (WES). The RNA is further studied across Gene Expression Analysis and Whole Transcriptome Sequencing. The Target Enrichment is further studied across Targeted Seq, WES, and Whole Exome Sequencing (WES).
  • Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis (SBS), and Single-molecule real-time (SMRT) Sequencing.
  • Based on Application, market is studied across Agricultural & Animal Research, Disease Diagnostics, and Drug Discovery. The Disease Diagnostics is further studied across Cancer Diagnostics, Infectious Disease Diagnostics, and Reproductive Health Diagnostics.
  • Based on End-User, market is studied across Academic Institutes and Research Centers, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
      • 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
      • 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in NGS sample preparation platforms
      • 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. NGS Sample Preparation Market, by Product

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Workstations

7. NGS Sample Preparation Market, by Workflow

  • 7.1. Introduction
  • 7.2. DNA
    • 7.2.1. Human Whole Genome Sequencing (WGS)
    • 7.2.2. Targeted Sequencing
    • 7.2.3. Whole Exome Sequencing (WES)
  • 7.3. Library Preparation
  • 7.4. Quality Control
  • 7.5. RNA
    • 7.5.1. Gene Expression Analysis
    • 7.5.2. Whole Transcriptome Sequencing
  • 7.6. Target Enrichment
    • 7.6.1. Targeted Seq
    • 7.6.2. WES
    • 7.6.3. Whole Exome Sequencing (WES)

8. NGS Sample Preparation Market, by Technology

  • 8.1. Introduction
  • 8.2. Ion Semiconductor Sequencing
  • 8.3. Nanopore Sequencing
  • 8.4. Sequencing by Synthesis (SBS)
  • 8.5. Single-molecule real-time (SMRT) Sequencing

9. NGS Sample Preparation Market, by Application

  • 9.1. Introduction
  • 9.2. Agricultural & Animal Research
  • 9.3. Disease Diagnostics
    • 9.3.1. Cancer Diagnostics
    • 9.3.2. Infectious Disease Diagnostics
    • 9.3.3. Reproductive Health Diagnostics
  • 9.4. Drug Discovery

10. NGS Sample Preparation Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Institutes and Research Centers
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Sample Preparation Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific NGS Sample Preparation Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa NGS Sample Preparation Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Agilent enhances user experience in NGS sample preparation workflow
    • 14.3.2. INTEGRA Biosciences Acquires Miroculus
    • 14.3.3. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
    • 14.3.4. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
    • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.6. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
    • 14.3.7. NGS KAPA Target Enrichment Product Launch
    • 14.3.8. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
    • 14.3.9. Introducing Tecan's MagicPrep NGS - the walkaway solution for your NGS library prep needs
    • 14.3.10. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Applied Biological Materials Inc.
  • 3. Aurora Biomed Inc.
  • 4. Beckman Coulter by Danaher Corporation
  • 5. BGI Group
  • 6. Bio-Rad Laboratories, Inc.
  • 7. BioDynami
  • 8. Eppendorf SE
  • 9. Eurofins Genomics LLC
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. FORMULATRIX, Inc.
  • 12. Illumina, Inc.
  • 13. Integrated DNA Technologies, Inc.
  • 14. Macrogen Inc.
  • 15. Magen Biotechnology Co., Ltd.
  • 16. MCLAB
  • 17. Merck KGaA
  • 18. New England Biolabs, Inc.
  • 19. Novogene Co., Ltd.
  • 20. Oxford Nanopore Technologies PLC
  • 21. PerkinElmer Inc.
  • 22. Promega Corporation
  • 23. Psomagen, Inc.
  • 24. Qiagen N.V.
  • 25. SPT Labtech Ltd
  • 26. Standard BioTools Inc.
  • 27. Sysmex Corporation
  • 28. Takara Bio Inc.
  • 29. Tecan Trading AG
  • 30. Thermo Fisher Scientific Inc.
  • 31. Twist Bioscience Corporation
  • 32. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. NGS SAMPLE PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. NGS SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NGS SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NGS SAMPLE PREPARATION MARKET DYNAMICS
  • TABLE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HUMAN WHOLE GENOME SEQUENCING (WGS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQ, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SEQUENCING BY SYNTHESIS (SBS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, B